Zhejiang Ausun Pharmaceutical Co., Ltd. (SHA:603229)
China flag China · Delayed Price · Currency is CNY
10.16
-0.16 (-1.55%)
May 12, 2026, 3:00 PM CST

SHA:603229 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
8,5488,2178,2957,8349,56410,451
Market Cap Growth
37.82%-0.94%5.87%-18.09%-8.49%19.25%
Enterprise Value
7,8817,4587,5727,1159,1839,848
Last Close Price
10.329.929.889.2211.8012.88
PE Ratio
76.8662.9340.1130.8640.6471.62
Forward PE
31.2734.2116.2922.5834.8754.34
PS Ratio
10.7610.3710.439.5912.5118.35
PB Ratio
3.613.623.653.666.558.33
P/TBV Ratio
3.863.883.923.947.369.58
P/FCF Ratio
334.37157.82124.50134.20--
P/OCF Ratio
70.9852.5046.6235.3279.3360.10
EV/Sales Ratio
9.929.419.528.7112.0117.29
EV/EBITDA Ratio
36.1035.0430.5024.9638.3254.04
EV/EBIT Ratio
55.8253.8040.7829.1044.7564.70
EV/FCF Ratio
308.26143.25113.66121.89--
Debt / Equity Ratio
0.210.200.120.140.170.09
Debt / EBITDA Ratio
2.232.151.091.061.010.60
Debt / FCF Ratio
19.028.774.095.19--
Net Debt / Equity Ratio
-0.28-0.34-0.36-0.38-0.25-0.45
Net Debt / EBITDA Ratio
-3.06-3.62-3.33-2.88-1.55-3.10
Net Debt / FCF Ratio
-26.11-14.79-12.40-14.062.454.12
Asset Turnover
0.250.260.270.310.370.35
Inventory Turnover
0.970.920.981.091.321.21
Quick Ratio
2.081.871.921.631.011.40
Current Ratio
2.642.472.532.171.531.92
Return on Equity (ROE)
4.56%5.75%9.37%14.09%17.33%12.25%
Return on Assets (ROA)
2.81%2.86%3.91%5.80%6.17%5.91%
Return on Invested Capital (ROIC)
8.79%8.91%11.56%17.71%21.20%24.91%
Return on Capital Employed (ROCE)
5.80%5.90%8.00%11.20%13.10%11.60%
Earnings Yield
1.26%1.59%2.49%3.24%2.46%1.40%
FCF Yield
0.30%0.63%0.80%0.74%-1.58%-1.31%
Dividend Yield
0.99%-1.01%1.00%0.48%0.29%
Payout Ratio
85.35%69.41%40.73%22.63%16.00%13.69%
Buyback Yield / Dilution
4.12%1.34%-0.99%-1.92%-1.16%-6.67%
Total Shareholder Return
5.11%1.34%0.02%-0.92%-0.68%-6.38%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.